Outcomes
EVENT, PULMONARY INVOLVEMENT, SECONDARY, REMISSION, EVENTS
The main outcome was KS-attributable mortality at 48 weeks; secondary outcomes were the incidence of severe-IRIS-KS events, that is the number of patients with a least one severe IRIS-KS event. We also describe in an exploratory way the overall mortality, the mortality in patients with Pulmonary KS, and the total number of IRIS-KS events in the EG and the CG as we observed patients with more than one severe IRIS-KS episode.Improvement of KS lesions and KS remission were assessed by comparing the size and number of KS lesions from baseline to 48-week visit comparing pictures taken at every visit, and lung CT-scan for cases with pulmonary involvement.